Updated:
Nexttobe
Erika Kjellberg Eriksson runs Nexttobe, a self-funded Swedish VC that has backed over 30 life-science and tech companies since 2011.
Nexttobe
Nexttobe AB is a private equity firm based in Uppsala, Sweden. It focuses on a Venture Capital strategy. The firm has a team of three employees.
General information
Firm type
Private Equity
Year founded
2011
AUM
Undisclosed
Location
Region
Europe
Country
Sweden
City
Uppsala
Corporate office
Uppsala, Sweden
Principals
Erika Kjellberg Eriksson
CEO and Chair of the Board
Per-Olof Wallström
Member of the Board
Angelica Loskog
Scientific adviser
Sector focus
Frequently asked questions
Who runs investment decisions at Nexttobe?
CEO and Chair Erika Kjellberg Eriksson leads the firm. She built her career as CFO of OxThera, Vice President and CFO of Q-Med, and CFO and CEO of BioPhausia before moving into venture leadership. Board member Per-Olof Wallström and scientific adviser Angelica Loskog provide deal-evaluation support, with Loskog bringing hands-on immunotherapy research directly from Uppsala University and portfolio company Lokon Pharma.
How is Nexttobe funded?
The firm is fully privately owned and self-capitalized. It does not solicit external LP commitments, which it says lets the team make faster decisions than a traditional venture fund. The source of the proprietary capital has not been publicly disclosed.
Does Nexttobe participate in fund commitments or only direct deals?
Nexttobe only makes direct equity investments. It does not invest as a limited partner in other venture funds or private equity vehicles. The firm takes active ownership positions and works alongside management teams to commercialize the underlying businesses.
What investment stages does Nexttobe target?
The firm focuses on early-phase projects with high scientific quality, spanning venture and growth equity. It emphasizes healthcare, medical devices, and specialty pharmaceuticals, while remaining open to technology and consumer companies when the idea is unique. The 30-plus portfolio includes both startups and more developed platforms like Hansa Biopharma and Q-linea.
Which sectors does Nexttobe explicitly avoid?
Nexttobe does not publish an explicit exclusion list. However, the portfolio concentrates on healthcare and life sciences, with a smaller set of technology and consumer companies. There is no evidence of investments in sectors such as fossil fuels, real estate, or traditional industrial manufacturing.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: